Anaplastic thyroid carcinoma: review of treatment protocols

Area of Science:

• Oncology
• Endocrinology

Background:

• Anaplastic thyroid carcinoma (ATC) is a rare, aggressive, and often fatal orphan disease.
• Current treatment options for ATC are limited, with no established therapies proven to prolong survival.

Purpose of the Study:

• To review existing treatment strategies for ATC, including multimodal approaches and emerging targeted therapies.
• To highlight the need for developing and prospectively evaluating novel treatment protocols for ATC.

Main Methods:

• Review of retrospective studies identifying prognostic markers and evaluating multimodal treatments (radiotherapy, chemotherapy).
• Analysis of recent case reports on targeted therapies for specific somatic alterations in ATC.
• Synthesis of conclusions from existing literature to inform future research directions.

Main Results:

• Retrospective studies have identified negative prognostic markers and analyzed the efficacy of various treatment combinations.
• Emerging targeted therapies show potential effectiveness in single case reports.
• Current evidence suggests a need for novel, comprehensive treatment strategies.

Conclusions:

• New treatment protocols for ATC should integrate surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy.
• Prospective evaluation of these combined treatment protocols is crucial to improve patient outcomes in clinical practice.